tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Buy Rating for KalVista Pharmaceuticals Amid Ekterly’s Market Launch and Insurance Challenges
PremiumRatingsBuy Rating for KalVista Pharmaceuticals Amid Ekterly’s Market Launch and Insurance Challenges
1M ago
KalVista price target lowered to $27 from $30 at H.C. Wainwright
Premium
The Fly
KalVista price target lowered to $27 from $30 at H.C. Wainwright
1M ago
KalVista price target raised to $37 from $22 at BofA
Premium
The Fly
KalVista price target raised to $37 from $22 at BofA
1M ago
Musk to launch new political party, Trump threatens BRICS tariff: Morning Buzz
PremiumThe FlyMusk to launch new political party, Trump threatens BRICS tariff: Morning Buzz
1M ago
KalVista Pharmaceuticals Gains FDA Approval for EKTERLY®
Premium
Company Announcements
KalVista Pharmaceuticals Gains FDA Approval for EKTERLY®
1M ago
KalVista announces FDA approval for EKTERLY
Premium
The Fly
KalVista announces FDA approval for EKTERLY
1M ago
KalVista selloff on Endpoints report unwarranted, says JonesResearch
PremiumThe FlyKalVista selloff on Endpoints report unwarranted, says JonesResearch
1M ago
FDA Commissioner pushed to reject KalVista drug, Endpoints News says
Premium
The Fly
FDA Commissioner pushed to reject KalVista drug, Endpoints News says
1M ago
KalVista volatile after Endpoints report on FDA Commissioner objection
Premium
The Fly
KalVista volatile after Endpoints report on FDA Commissioner objection
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100